Ali Nabavizadeh, MD
Radiology
Accepting new patients
Sees patients age 18 and up
Headshot of Ali Nabavizadeh, MD
Penn Medicine Provider

About me

  • Associate Professor of Radiology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Shiraz University of Medical Sciences
  • Residency: Sea Mar Olympia Medical Clinic
  • Fellowship: Children's Hospital of Philadelphia
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nabavizadeh is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Maoz SL, Lee M, Fischer JL, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Pinheiro-Neto CD, Chan EP, Roozdar P, Abuzeid WM, Chang EH, Jafari A, Kingdom TT, Kohanski MA, Lee JK, Lazor JW, Nabavizadeh A, Nayak JV, Palmer JN, Patel ZM, Resnick AC, Smith TL, Snyderman CH, St. John MA, Storm PB, Suh JD, Wang MB, Sim MS, Beswick DM. Minimal Clinically Important Difference of the Sinonasal Outcome Test in Sinonasal Malignancy , Annals of Otology, Rhinology & Laryngology.: 2026,34894261428393


Li EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, Young AJ, Schubert E, Aboian M, Doot R, Ware JB, Pantel AR, Binder ZA, Storm PB, Resnick AC, Amankulor NM, O'Rourke DM, Desai A, Nasrallah MP, Brem S, Bagley SJ, Mankoff D, Nabavizadeh A Metabolic imaging and molecular signatures reveal metabolic phenotypes in recurrent glioblastoma , Journal of Nuclear Medicine: 2026,jnumed.125.271476


Tak D, Garomsa BA, Chaunzwa TL, Zapaishchykova A, Climent Pardo JC, Ye Z, Zielke J, Ravipati Y, Vajapeyam S, Mahootiha M, Smith C, Familiar AM, Liu KX, Prabhu S, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Huang RY, Poussaint TY, Kann BH. A generalizable foundation model for analysis of human brain MRI , Nature Neuroscience: 2026


Kotecha R, Chiang V, Tom MC, Parent E, Nabavizadeh A, Zane E, Peddi S, Sulman EP, Siegel BA, Huang J, Brem S, Ware M, Kesari S, Pope W, Holmes R, Chau A, Teoh EJ, Chao ST, Aboian M 18F-Fluciclovine Positron Emission Tomography for Detection of Recurrent Brain Metastases after Radiotherapy: Image Interpretation Criteria, Diagnostic Performance, and Safety from the Phase 2b PURSUE Study , International Journal of Radiation Oncology, Biology, Physics: 2026,S0360-3016(26)00431-1


Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF. AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors , NPJ Precis Oncol , 10(1): 2026,63


Ivanidze J, Vu KV, Fu R, Brandmaier A, Szidonya L, Choudhary G, Starkey J, Wang TJ, Sisti M, McKhann LG, Puri S, Konner M, Roytman M, Lin E, Kuhn A, Osborne JR, Stieg PE, Beal K, Ramakrishna RR, Singh G, Lignelli-Dipple A, Doubrovin M, Vo AH, Welch M, Iwamoto F, Haggiagi A, Donovan L, Diaz M, Gill B, Liechty B, Pisapia DJ, Walker J, Magge RS, Wood M, Corzo VM, Sanusi OR, Raslan A, Dogan A, Bowden S, Nehmeh SA, Nickerson J, Mallak N, Ruiz A, Ambady P, Nabavizadeh A, Barajas RF Jr. Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma , AJNR Am J Neuroradiol : 2025,ajnr.A9120


Jung G, Liang Z, Jain P, Deutsch HM, Li F, Rathi KS, Sun Z, Chen X, Straka J, Kazerooni AF, Sun Y, Koptyra MP, Sanchez-Maldonado S, Familiar A, Waanders AJ, Nabavizadeh A, Huang X, Resnick AC, Song Y. Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltration , NPJ Precis Oncol , 9(1): 2025,344


Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S. Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005 , Clin Cancer Res , 31(16): 2025,3463-3475


Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, Gopikrishna GK, Rech AJ, Nabavizadeh A, Bagley LJ, Park J, Jarocha D, Martins R, Sarmiento N, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz RM, Jadlowsky JK, Mackey S, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Barrett D, Colbourn R, Nasrallah MP, Mourelatos Z, Hwang WT, Alanio C, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM. Intracerebroventricular bivalent CAR T cells targeting EGFR epitope 806 and IL-13Rα2 in recurrent glioblastoma: a phase 1 dose finding study , Nature Medicine, 31(8): 2025,2778-2787


Climent Pardo JC, Zapaishchykova A, Boyd A, Tak D, Zielke J, Mahootiha M, Ye Z, Vajapeyam S, Jones J, Smith C, Familiar AM, Nabavizadeh A, Bandopadhayay P, Mueller S, Aerts HJWL, Haas-Kogan DA, Michor F, Ligon KL, Poussaint TY, Faghihroohi S, Kann BH. Deep learning volumetrics reveal distinct clinical trajectories for pediatric low-grade gliomas under surveillance: A multicenter study , Neurooncol Adv, 7(1): 2025,vdaf145


View all publications